/Investor DB

Amplify Partners — 2018 Investments

5 investments dated 2018 · listed companies and verified rows first · show all

InterVenn Biosciencesintervenn.comDec 2018 · $9M

InterVenn applies glycoproteomics combined with artificial intelligence to study women's health conditions such as ovarian cancer and endometriosis, mapping glycoprotein control points linked to disease progression.

AI & Machine LearningBiotechFemTech

Aldo Carrascoso(Founder)Carlito Lebrilla(Founder)inCarolyn Bertozzi(Founder)

Co-investorsAnzu PartnersGenoa VenturesSoftBank Vision FundXeraya CapitalTrue Ventures

PicnicAIpicnic.aiin𝕏Series A · Jan 2018 · $10M

PicnicAI applies AI to care delivery and clinical research, offering patient-facing tools that unify a person's medical records across providers and AI-driven services that speed up and reduce the cost of drug development.

AI & Machine LearningBiotechDigital HealthHealthtechSan Francisco, US

Noga Leviner(CEO)inTroy Astorino(CTO)inLuna Federici(Chief Executive Officer)inJustin Maslin(Software Engineer)Shannah Metz(Recruiter)Stephanie Iannello(Recruiting)

Co-investorsY CombinatorB Capital GroupDeNAFelicis VenturesForesite CapitalGreat Oaks Venture Capital+7 more

Strangeworksstrangeworks.comin𝕏Seed · Jun 2018 · $4M

Strangeworks provides optimization and quantum computing services, combining embedded PhD-level specialists with a heterogeneous hybrid compute platform and an agent product called Aura to turn complex operational problems into production systems.

AI & Machine LearningDeep TechEnterprise SoftwareQuantum ComputingAustin, US

whurley(Founder & CEO)inJustin Youens(Founder)inWilliam Hurley(Founder)

Co-investorsBoxGroupHitachi VenturesEcliptic CapitalGreatPoint VenturesHitachi, Ltd.Lightspeed Venture Partners+2 more

VeriSIM Lifeverisimlife.comin𝕏Pre-Seed · Jan 2018 · $1M

VeriSIM uses machine learning and computational simulation to accelerate drug development, replacing traditional trial-and-error experimentation with computational prediction to improve success rates and reduce animal testing.

AI & Machine LearningBiotechDigital HealthMedical DevicesSan Francisco, US

Jo Varshney(Founder & Chief Executive Officer)inDr. Vivek Gupta, Ph.D.(Scientific Co-Founder)

Co-investorsCerity Partners VenturesColorcon VenturesDebiopharm Innovation FundDeepwater Asset ManagementIntel CapitalLoup Ventures+8 more

Wasokowasoko.comin𝕏Jul 2018

Wasoko is an e-commerce platform providing convenient and cost-effective access to products and services for shopkeepers and small businesses across Africa, offering same-day delivery and flexible payment options.

B2B MarketplacesE-commerceImpact & Social Good

Daniel Yu(Founder)in

Co-investors4Di Capital4DX VenturesAHL Venture PartnersAvenir Growth CapitalBreyer CapitalFlucas Ventures+21 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.